100 results on '"Nijhuis, M."'
Search Results
2. INVESTIGATION OF THE CENTRAL NERVOUS SYSTEM AS A VIRAL RESERVOIR FOR HIV
3. INVESTIGATION OF THE CENTRAL NERVOUS SYSTEM AS A VIRAL RESERVOIR FOR HIV
4. In-depth Characterization of Vaccine Breakthrough Infections With SARS-CoV-2 Among Health Care Workers in a Dutch Academic Medical Center.
5. Characterization of HIV-1 Infection in Microglia-Containing Human Cerebral Organoids.
6. HIV Treatment Monitoring in Resource-Limited Settings: Current Paradigms and Future Strategies
7. Characterization of HIV-1 Infection in Microglia-Containing Human Cerebral Organoids.
8. Shock and kill within the CNS: A promising HIV eradication approach?
9. HIV Treatment Monitoring in Resource-Limited Settings: Current Paradigms and Future Strategies
10. Prolonged SARS-CoV-2 RNA shedding in a young man recovering from traumatic pneumothorax
11. Point-of-Care Detection of Nonadherence to Antiretroviral Treatment for HIV-1 in Resource-Limited Settings Using Drug Level Testing for Efavirenz, Lopinavir, and Dolutegravir: A Validation and Pharmacokinetic Simulation Study
12. Point-of-Care Detection of Nonadherence to Antiretroviral Treatment for HIV-1 in Resource-Limited Settings Using Drug Level Testing for Efavirenz, Lopinavir, and Dolutegravir: A Validation and Pharmacokinetic Simulation Study
13. Drug level testing as a strategy to determine eligibility for drug resistance testing after failure of ART: a retrospective analysis of South African adult patients on second-line ART
14. Drug level testing as a strategy to determine eligibility for drug resistance testing after failure of ART: a retrospective analysis of South African adult patients on second-line ART
15. Drug level testing as a strategy to determine eligibility for drug resistance testing after failure of ART: a retrospective analysis of South African adult patients on second-line ART
16. Incorporating network uncertainties in voltage dip state estimation
17. Integrating direct and indirect load control for congestion management in LV networks
18. Incorporating network uncertainties in voltage dip state estimation
19. Integrating direct and indirect load control for congestion management in LV networks
20. The antiretroviral CCR5-inhibitor maraviroc effectively reverses HIV latency by phosphorylation of Nf-kappa B
21. The antiretroviral CCR5-inhibitor maraviroc effectively reverses HIV latency by phosphorylation of Nf-kappa B
22. Rapid rebound of a highly replication competent preexisting CXCR4-tropic HIV variant after allogeneic stem cell transplantation with CCR5D32 stem cells
23. The antiretroviral CCR5-inhibitor maraviroc effectively reverses HIV latency by phosphorylation of Nf-kappa B
24. The antiretroviral CCR5-inhibitor maraviroc effectively reverses HIV latency by phosphorylation of Nf-kappa B
25. Rapid rebound of a highly replication competent preexisting CXCR4-tropic HIV variant after allogeneic stem cell transplantation with CCR5D32 stem cells
26. Acid-based formula with synbiotics modifies gut microbiota in non-ige mediated cow's milk allergic infants
27. Amino acid-based formula including specific synbiotics modifies the gut microbiota and reduces clinical symptoms in non-IgE mediated cow's milk allergic infants
28. Gaussian mixture based probabilistic load flow For LV-network planning
29. Stochastic residential harmonic source modeling for grid impact studies
30. Analysis of reflectivity & predictability of electricity network tariff structures for household consumers
31. Long-term planning of low voltage networks
32. Valuation of measurement data for low voltage network expansion planning
33. Analysis of reflectivity & predictability of electricity network tariff structures for household consumers
34. Valuation of measurement data for low voltage network expansion planning
35. Long-term planning of low voltage networks
36. Stochastic residential harmonic source modeling for grid impact studies
37. Gaussian mixture based probabilistic load flow For LV-network planning
38. Clinical outcome of maraviroc-containing therapy in heavily pre-treated HIV-1-infected patients
39. Clinical outcome of maraviroc-containing therapy in heavily pre-treated HIV-1-infected patients
40. Treatment of HIV and acute myeloid leukemia by allogeneic CCR5-d32 blood stem cell transplantation
41. Bottom-up Markov Chain Monte Carlo approach for scenario based residential load modelling with publicly available data
42. Clinical outcome of maraviroc-containing therapy in heavily pre-treated HIV-1-infected patients
43. Clinical outcome of maraviroc-containing therapy in heavily pre-treated HIV-1-infected patients
44. Treatment of HIV and acute myeloid leukemia by allogeneic CCR5-d32 blood stem cell transplantation
45. Bottom-up Markov Chain Monte Carlo approach for scenario based residential load modelling with publicly available data
46. Complex T-Cell Receptor Repertoire Dynamics Underlie the CD8(+) T-Cell Response to HIV-1
47. Comparison of digital PCR platforms and semi-nested qPCR as a tool to determine the size of the HIV reservoir
48. Short Communication: In Vitro Accumulation of Drug Resistance Mutations in Chimeric Infectious Clones Containing Subtype B or C Reverse Transcriptase and Selected with Tenofovir or Didanosine
49. Short Communication: In Vitro Accumulation of Drug Resistance Mutations in Chimeric Infectious Clones Containing Subtype B or C Reverse Transcriptase and Selected with Tenofovir or Didanosine
50. Complex T-Cell Receptor Repertoire Dynamics Underlie the CD8(+) T-Cell Response to HIV-1
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.